- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01120548
Sleep Apnea Treatment During Cardiac Rehabilitation of Congestive Heart Failure Patients (SATELIT-HF)
SLEEP DISORDERED BREATHING DURING CARDIAC REHABILITATION A Study of the Improvement in Physical Performance of Patients With Heart Failure During Cardiac Rehabilitation Due to the Correction of Sleep Disordered Breathing
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Controlled, randomised, multicentre study. Patients will be assessed prior to starting the rehabilitation programme with regard to exercise tolerance parameters (cardiopulmonary exercise test, 6 minute walk test), ultrasound parameters and biological parameters (Na, Hb, BNP).
The cardiac rehabilitation programme will include education, secondary prevention and physical training components in each of the two groups. The physical training component will include a minimal "base" of activities that is identical for both groups. The nocturnal therapy device will be adapted to the type of SDB specific to each patient (central, mixed, obstructive). The randomisation will be stratified by centre according to predictive factors for performance improvement during rehabilitation.
The main objective is to evaluate the improvement in physical performance resulting from adapted ventilation on SDB compared to physical training alone in patients with heart failure.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Briis sous Forges, France, 91640
- Centre Medical de Bligny
-
Châtillon, France, 92320
- Clinique de Châtillon
-
Créteil, France, 94000
- Hôpital Albert Chenevier
-
Dieulefit, France, 26220
- Dieulefit Santé
-
Dinard, France, 35800
- Hopital Arthur Gardiner
-
Durtol, France, 63830
- Clinique de cardiopneumologie
-
Echirolles, France, 38130
- Hôpital Sud - Institut de Rééducation
-
Issy-les-moulineaux, France, 92133
- Hôpital Corentin Celton
-
Lomme, France, 59160
- Clinique de la Mitterie
-
Marcy l'Etoile, France, 69280
- Centre IRIS
-
Marseille, France, 13009
- Centre Cardio-Vasculaire Valmante
-
Puilboreau, France, 17138
- Clinique de réadaptation cardiaque Cardiocéan
-
Saint Etienne, France, 42055
- Hôpital Nord 6
-
Saint Julien en Genevois, France, 74164
- Hôpital Intercommunal Sud Léman Valserine
-
Saint Martin d'Aubigny, France, 50190
- Centre William Harvey - le Haut Boscq
-
Tracy le Mont, France, 60170
- Centre de réadaptation cardiaque Leopold Bellan
-
Vandoeuvre-les-Nancy, France, 54500
- Institut Régional de Réadaptation
-
Vence, France, 06140
- La Maison du Mineur
-
Yerres, France, 91330
- Centre Hospitalier Calmette
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who have NYHA class II to IIIb heart failure, operated or not, ischemic or not, without significant valve pathology.
- Referred to cardiac rehabilitation
- With an EF < 40%
- And an apnea-hypopnea index > 15/h (determined by a nasal flow recording method)
- Have signed the consent document to participate in the study.
Exclusion Criteria:
- Patients who have been stabilised for less than 10 days (inotropic drugs or modification of the anticipated resynchronisation or PM parameters)
- Patients who already use sleep disordered breathing devices
- Resting SBP < 80 mmHg (averaged over 3 separate measurements)
- Recent angioplasty (within the last 10 days)
- Infarction within the last 10 days
- Heart surgery within the last 15 days
- Valve dysfunction requiring surgery
- Uncontrolled high blood pressure (BP > 180 and/or 110 mmHg)
- Anaemia (Hb < 9g/dl)
- Haemodialysis
- Patient receiving circulatory assistance
- Severe chronic respiratory failure (FEV1 < 1000) or hypercapnia greater than 46 mmHg
- Patient incapable of performing a 6 minute walk test and an exercise test
- Absolute contraindication for an exercise test and/or physical training according to the recommendations of the French Society of Cardiology
- Evolving myopericarditis
- Severe ventricular rhythm disorders that do not stabilise with treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Rehabilitation + Ventilation Group
Patient Heart Failure with sleep disordered breathing who follows ventilation therapy and physical training.
|
The service provider will provide the patient with the ventilation device and will explain to the patient how to operate the device and how to fit the mask according to the specifications. There will be an oximetry recording during ventilation on the first night. After the first night, the ventilation parameters recorded by the machine and the oximetry results will be read and used to adjust the settings. Starting the first week and at the end of the programme, the following ventilation parameters will be collected: compliance, leaks, AHI, ventilation mode, pressures used. The threshold of length of nocturnal ventilation fixed to 3h per night on average in order to consider a compliant patient. |
|
NO_INTERVENTION: Rehabilitation Only Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak VO2
Time Frame: Day 1
|
The primary endpoint is the relative improvement of exercise tolerance, estimated using the changes in the patient's peak VO2 measured before starting and after finishing the rehabilitation programme between the both group.
|
Day 1
|
|
Peak VO2
Time Frame: Between 4 to 9 weeks
|
The primary endpoint is the relative improvement of exercise tolerance, estimated using the changes in the patient's peak VO2 measured before starting and after finishing the rehabilitation programme between the both group.
|
Between 4 to 9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical training compliance
Time Frame: between 4 and 9 weeks
|
Secondary endpoints include compliance with rehabilitation sessions, estimated by comparing the number of sessions in which training was effectively carried out with the anticipated number of sessions and other exercise tolerance parameters (maximum power, duration of exercise, submaximal parameters) in each group.
|
between 4 and 9 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sonia Corone, MD, Centre Medical de Bligny
- Principal Investigator: Marie-Christine Iliou, MD, Hôpital Corentin Celton
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.